Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Gastrointestinal 1CNS 1

Conditions

Endometrial Neoplasms 3Ovarian Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Sarcoma 1Pregnancy Complications 1Overweight 1Obesity 1Leiomyoma 1Inflammation 1Infertility, Female 1Infertility 1Colorectal Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 3Fluorodeoxyglucose F18 3pembrolizumab 2Radiosurgery 2Paclitaxel 2Nivolumab 2Ipilimumab 2FAPI-46 2tipifarnib 1sodium thiosulfate 1sargramostim 1regorafenib 1montelukast 1entrectinib 1entinostat 1cediranib 1cc-486 1carboxyamido-triazole 1alectinib 1aflibercept 1Trastuzumab 1Thiotepa 1Tablets 1Specimen Handling 1Sirolimus 1Sevoflurane 1Ritonavir 1Restraint, Physical 1Radiotherapy 1Quality of Life 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × Tablets × Gynecologic × Clear all
NCT06887673 2025-03-20

Lipid Mediators & Cancer: Montelukast, SPM, and Almonds

University of South Florida

Phase EARLY_PHASE1 Not yet recruiting
56 enrolled
CNSGastrointestinalGynecologicSarcoma

Brain Neoplasms, Inflammation, Ovarian Neoplasms, Sarcoma, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡